Log In
BCIQ
Print this Print this
 

Lysyl oxidase-like 2 (LOXL2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Lysyl oxidase-like 2 (LOXL2)

BCIQ
Print ChartPrint this
Phase II, 1 Phase II, 1 Phase II, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase II
Cancer

-

1

Hematology

-

1

Hepatic

1

1




 Products Targeting Lysyl oxidase-like 2 (LOXL2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$225.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/05/2015

Undisclosed

Undisclosed

Undisclosed

01/31/2011

Undisclosed

$225.0M

Undisclosed

Get a free BioCentury Trial today